Similar Articles

Glucagon-Like Peptide-1 and Psychiatric Disorder

Ayşe Şiva Acar, Oytun Erbaş

DOI: 10.5606/jebms.2021.75645

Issue: 2021, Volume 2 - Issue 2
1543 1167

Synaptic Vesicle Protein 2A: Basic Facts and Roles in Schizophrenia

Aylin Kayaaltı, Berzah Güneş, Oytun Erbaş

DOI: 10.5606/jebms.2021.75677

Issue: 2021, Volume 2 - Issue 3
1080 349

Neuregulin 1 and Its Roles in Schizophrenia: A Systematic Review

Dildar Savcı, Sultan Karadeniz, Oytun Erbaş

DOI: 10.5606/jebms.2021.75683

Issue: 2021, Volume 2 - Issue 3
510 452

Gluten and Casein: Their Roles in Psychiatric Disorders

Ayşegül Şimal Ulaş, Arzu Çakır, , Oytun Erbaş

DOI: 10.5606/jebms.2022.1003

Issue: 2022, Volume 3 - Issue 1
2557 807

Understanding the Role of DISC1 in Psychiatric Disorders

Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1011

Issue: 2022, Volume 3 - Issue 1
589 302

Association of NOS1AP Variants in Schizophrenia

Ayşenur Saygılı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1013

Issue: 2022, Volume 3 - Issue 1
569 342

Schizophrenia Susceptibility Genes

Beyza Nur Akı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1027

Issue: 2022, Volume 3 - Issue
306 316

An Overview of Antipsychotics: Mechanisms of Action

Öznur Demirci, İrem Adar, Oytun Erbaş

DOI: 10.5606/jebms.2023.1047

Issue: 2023, Volume 4 - Issue 1
895 401